- Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens
-
Chen CA, Chiang CJ, Chen YY, You SL, Hsieh SF, Tang CH, Cheng WF
- KMID: 2395243
- J Gynecol Oncol.
- 2018 Jan;29(1):e16.
- doi: 10.3802/jgo.2018.29.e16
OBJECTIVE: Adjuvant chemotherapy was introduced in patients with early-stage ovarian cancer (OC). The benefit of standard chemotherapeutic regimens including taxane has not been established. METHODS: Patients with early-stage OC from the... -
- CITED
-
- Close
- SHARE
-
- Close
